Evidence map›Paper›PMID 41822471›Full record

ArticleFrontiers in immunology2026

Characterization of subchronic lung and brain consequences caused by mouse-adapted SARS-CoV-2 and influenza A infection of C57BL6 mice.

Joshua Currey, Chenxiao Wang, Meredith G Mayer, Yilin Chen, Ana Karina Nisperuza Vidal, Michaela J Allen, Mst Shamima Khatun, Calder R Ellsworth, Mohammad Islamuddin, Jefferson Evangelista and 9 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Joshua Currey *Tulane National Biomedical Research Center, Covington, LA, United States.
Chenxiao Wang *Tulane National Biomedical Research Center, Covington, LA, United States.
Meredith G MayerTulane National Biomedical Research Center, Covington, LA, United States.
Yilin ChenTulane National Biomedical Research Center, Covington, LA, United States.
Ana Karina Nisperuza VidalTulane National Biomedical Research Center, Covington, LA, United States.
Michaela J AllenCenter for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA, United States.
Mst Shamima KhatunCenter for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA, United States.
Calder R EllsworthTulane National Biomedical Research Center, Covington, LA, United States.
Mohammad IslamuddinTulane National Biomedical Research Center, Covington, LA, United States.
Jefferson EvangelistaTulane National Biomedical Research Center, Covington, LA, United States.
Skye M MinorTulane National Biomedical Research Center, Covington, LA, United States.
Nadia GoldenTulane National Biomedical Research Center, Covington, LA, United States.
Kevin J ZwezdarykDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, United States.
Nicholas J ManessTulane National Biomedical Research Center, Covington, LA, United States.
Robert V BlairTulane National Biomedical Research Center, Covington, LA, United States.
Jay K KollsCenter for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA, United States.
Derek A PociaskCenter for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA, United States.
Tracy FischerTulane National Biomedical Research Center, Covington, LA, United States.
Xuebin QinTulane National Biomedical Research Center, Covington, LA, United States.

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
The Role of Viral Exposure and Age in Alzheimer's Disease ProgressionR01AG082899 · NIA · TULANE UNIVERSITY OF LOUISIANA · PI Kevin John Zwezdaryk · 2023 to 2026
$2.1M
NIA NIH HHS R01 AG082899NIH HHS P51 OD011104
6 · The paper itself

Abstract

Introduction: SARS-CoV-2 and, to a lesser extent, influenza A can lead to long-term complications in the respiratory and nervous systems. However, the mechanisms driving post-viral sequelae remain poorly understood. Methods: To address this gap, we longitudinally characterized C57BL/6 mice infected with sublethal doses of mouse-adapted SARS-CoV-2 (MA30) or influenza A (PR8). Lung and brain tissues were analyzed at 14-, 21-, and 28-days post-infection (DPI) using histological analysis and bulk-RNA sequencing. Results: In the lungs, both infections caused prolonged inflammation and fibrosis. MA30-infected lungs showed persistent upregulation of inflammation, coagulation, complement, as well as fibrotic, and extracellular matrix (ECM) remodeling pathways at 21 DPI, alongside downregulation of epithelial junction and metabolic program pathways. In contrast, PR8-infected lungs exhibited a strong acute interferon response and chronic upregulation of basal epithelial markers (e.g., Discussion: Together, these findings establish distinct tissue-specific trajectories of long-term pathology following SARS-CoV-2 and influenza infection and provide a foundation for dissecting the mechanisms of post-viral lung and brain disease.

Indexed as

BrainCOVID-19Influenza A virusLungOrthomyxoviridae InfectionsSARS-CoV-2AnimalsDisease Models, AnimalFemaleMiceMice, Inbred C57BLPost-Acute COVID-19 Syndromebraininfluenzalong COVIDlungMA30mouse modelPR8SARS-CoV-2

Identifiers

PMID41822471
PMCPMC12975924

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.